Zhenyu Ding

6.0k citations

84 papers · 1.4k indexed · h-index 20

Impact in

Oncology top 5%
- Cancer Immunotherapy and Biomarkers
- Lung Cancer Research Studies
- CAR-T cell therapy research
Immunology top 10%
- Immunotherapy and Immune Responses
- Immune Cell Function and Interaction

Papers in ⓘ

Oncology 50
- Cancer Immunotherapy and Biomarkers 19
- Lung Cancer Research Studies 17
- Colorectal Cancer Treatments and Studies 7
Pulmonary and Respiratory Medicine 30
- Lung Cancer Treatments and Mutations 16
- Lung Cancer Diagnosis and Treatment 8

Co-authors: Yuquan Wei (11 shared papers)Jiyan Liu (6 shared papers)Guihong Liu (6 shared papers)Peipei Wang (10 shared papers)Qing Li (8 shared papers)Heng Xu (8 shared papers)Yaomei Tian (3 shared papers)Bailing Zhou (4 shared papers)
Journals: Frontiers in Pharmacology (5 papers)Journal of Clinical Oncology (4 papers)Scientific Reports (2 papers)Clinical Cancer Research (2 papers)BMC Cancer (2 papers)
Partner nations: China United States South Korea

In The Last Decade

Zhenyu Ding

76 papers receiving 1.4k citations

Peers

Countries citing papers authored by Zhenyu Ding

Since Specialization

Citations

This map shows the geographic impact of Zhenyu Ding's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhenyu Ding with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhenyu Ding more than expected).

Fields of papers citing papers by Zhenyu Ding

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zhenyu Ding. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhenyu Ding. The network helps show where Zhenyu Ding may publish in the future.

Co-authors

The 25 scholars most cited alongside Zhenyu Ding, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Zhenyu Ding Line = papers co-authored together Zhenyu Ding links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 84 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Inhibition of FGF‐FGFR and VEGF‐VEGFR signalling in cancer treatment Cell Proliferation ·Guihong Liu, Tao Chen, Zhenyu Ding, Yang Wang, Yuquan Wei, Xiawei Wei	2021	115
2	DP7-C-modified liposomes enhance immune responses and the antitumor effect of a neoantigen-based mRNA vaccine Journal of Controlled Release ·Rui Zhang, Lin Tang, Yaomei Tian, Ji Xiao, Qiuyue Hu, Bailing Zhou, Zhenyu Ding, Heng Xu, Li Yang	2020	81
3	Immune Checkpoint Inhibitor-Associated Cardiotoxicity: Current Understanding on Its Mechanism, Diagnosis and Management Frontiers in Pharmacology ·Yuwen Zhou, Yajuan Zhu, Man‐Ni Wang, Yao Xie, Chao-Yue Chen, Tao Zhang, Fan Xia, Zhenyu Ding, Jiyan Liu	2019	77
4	The composition and distribution of chemicals and isotopes in precipitation in the Shiyang River system, northwestern China Journal of Hydrology ·Jinzhu Ma, Peng Zhang, Gaofeng Zhu, Yunquan Wang, W.M. Edmunds, Zhenyu Ding, Jianhua He	2012	75
5	Safety and Efficacy of Therapeutic Cancer Vaccines Alone or in Combination With Immune Checkpoint Inhibitors in Cancer Treatment Frontiers in Pharmacology ·Jing Zhao, Ye Chen, Zhenyu Ding, Jiyan Liu	2019	64
6	A Novel Nomogram and Risk Classification System Predicting the Cancer-Specific Survival of Patients with Initially Diagnosed Metastatic Esophageal Cancer: A SEER-Based Study Annals of Surgical Oncology ·Xin Tang, Xiaojuan Zhou, Yanying Li, Xue Tian, Yongsheng Wang, Meijuan Huang, Li Ren, Lin Zhou, Zhenyu Ding, Jiang Zhu, Yong Xu, Feng Peng, Jin Wang, You Lü, Youling Gong	2018	62
7	Increased coexpression of PD-L1 and TIM3/TIGIT is associated with poor overall survival of patients with esophageal squamous cell carcinoma Journal for ImmunoTherapy of Cancer ·Peipei Wang, Yueyun Chen, Qingqin Long, Qing Li, Jiangfang Tian, Ting Liu, Yong Wu, Zhenyu Ding	2021	60
8	Improved Therapeutic Effectiveness by Combining Recombinant CXC Chemokine Ligand 10 with Cisplatin in Solid Tumors Clinical Cancer Research ·Gang Li, Ling Tian, Jianmei Hou, Zhenyu Ding, Qiuming He, Ping Feng, Yanjun Wen, Fei Xiao, Bing Yao, Ru Zhang, Feng Peng, Yu Jiang, Feng Luo, Xia Zhao, Lin Zhang, Qiao Zhou, Yuquan Wei	2005	59
9	Personalized neoantigen-pulsed dendritic cell vaccines show superior immunogenicity to neoantigen-adjuvant vaccines in mouse tumor models Cancer Immunology Immunotherapy ·Rui Zhang, Fengjiao Yuan, Yang Shu, Yaomei Tian, Bailing Zhou, Linglu Yi, Xueyan Zhang, Zhenyu Ding, Heng Xu, Li Yang	2019	57
10	Cholesterol-modified DP7 enhances the effect of individualized cancer immunotherapy based on neoantigens Biomaterials ·Rui Zhang, Lin Tang, Yaomei Tian, Ji Xiao, Qiuyue Hu, Bailing Zhou, Zhenyu Ding, Heng Xu, Li Yang	2020	46
11	Combination of low‐dose cisplatin and recombinant xenogeneic endoglin as a vaccine induces synergistic antitumor activities International Journal of Cancer ·Guang‐Hong Tan, Ling Tian, Yuquan Wei, Xia Zhao, Jiong Li, Yang Wu, Yanjun Wen, Tao Yi, Zhenyu Ding, Bin Kan, Yong-Qiu Mao, Hongxin Deng, Hong‐li Li, Chun‐Hua Zou, Chunhua Fu	2004	35
12	Neoantigen: A Promising Target for the Immunotherapy of Colorectal Cancer Disease Markers ·Yue Zheng, Yang Fu, Peipei Wang, Zhenyu Ding	2022	33
13	Thyroid function abnormality induced by PD-1 inhibitors have a positive impact on survival in patients with non-small cell lung cancer International Immunopharmacology ·Yuwen Zhou, Ruolan Xia, Huilang Xiao, Dan Pu, Yixiu Long, Zhenyu Ding, Jiyan Liu, Xuelei Ma	2020	30
14	PD-1 Inhibitors in the Advanced Esophageal Cancer Frontiers in Pharmacology ·Ye Hong, Zhenyu Ding	2019	29
15	Predicting severe acute radiation pneumonitis in patients with non-small cell lung cancer receiving postoperative radiotherapy: Development and internal validation of a nomogram based on the clinical and dose–volume histogram parameters Radiotherapy and Oncology ·Xin Tang, Yanying Li, Xue Tian, Xiaojuan Zhou, Yongsheng Wang, Meijuan Huang, Li Ren, Lin Zhou, Jianxin Xue, Zhenyu Ding, Jiang Zhu, Yong Xu, Feng Peng, Jin Wang, You Lü, Youling Gong	2018	28
16	Impact of whole brain radiation therapy on CSF penetration ability of Icotinib in EGFR-mutated non-small cell lung cancer patients with brain metastases: Results of phase I dose-escalation study Lung Cancer ·Lin Zhou, Jiazhuo He, Weijie Xiong, Yongmei Liu, Jing Xiang, Yu Qin, Maozhi Liang, Xiaojuan Zhou, Zhenyu Ding, Meijuan Huang, Li Ren, Jiang Zhu, Lu Li, Mei Hou, Lieming Ding, Fenlai Tan, You Lü	2016	26
17	Combination of Low-Dose Gemcitabine and Recombinant Quail Vascular Endothelial Growth Factor Receptor-2 as a Vaccine Induces Synergistic Antitumor Activities Oncology ·Jianmei Hou, Jiyan Liu, Yang Li, Xia Zhao, Ling Tian, Zhenyu Ding, Yanjun Wen, Ting Niu, Fei Xiao, Yanyan Lou, Guang‐Hong Tan, Hongxin Deng, Jiong Li, Jinliang Yang, Yong-Qiu Mao, Bing Kan, Yang Wu, Qiu Li, Yuquan Wei	2005	25
18	The Ways of Isolating Neoantigen-Specific T Cells Frontiers in Oncology ·Qing Li, Zhenyu Ding	2020	24
19	Neutrophil-Lymphocyte Ratio as a Prognostic Marker for Chemotherapy in Advanced Lung Cancer The International Journal of Biological Markers ·Zhulin Liu, Tingting Zeng, Xiaojuan Zhou, Yanv Ren, Lei Zhang, Xin‐Xing Zhang, Zhenyu Ding	2016	23
20	Improved therapeutic efficacy against murine carcinoma by combining honokiol with gene therapy of PNAS‐4, a novel pro‐apoptotic gene Cancer Science ·Zhu Yuan, Huanyi Liu, Fei Yan, Yongsheng Wang, Lantu Gou, Chunlai Nie, Zhenyu Ding, Songtao Lai, Yuwei Zhao, Xinyu Zhao, Jiong Li, Hongxin Deng, Yong-Qiu Mao, Lijuan Chen, Yuquan Wei, Xia Zhao	2009	21

About Zhenyu Ding

Zhenyu Ding is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Molecular Biology, Immunology and Surgery, having authored 84 papers that have together received 1.4k indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (19 papers), Immunotherapy and Immune Responses (17 papers), Lung Cancer Research Studies (17 papers), Lung Cancer Treatments and Mutations (16 papers), Esophageal Cancer Research and Treatment (9 papers), Lung Cancer Diagnosis and Treatment (8 papers), Colorectal Cancer Treatments and Studies (7 papers) and Angiogenesis and VEGF in Cancer (6 papers). The work is most often cited by research in Oncology (710 citations), Immunology (392 citations), Geochemistry and Petrology (61 citations), Pulmonary and Respiratory Medicine (346 citations) and Cancer Research (145 citations). Zhenyu Ding has collaborated with scholars based in China, United States and South Korea. Frequent co-authors include Yuquan Wei, Jiyan Liu, Guihong Liu, Peipei Wang, Qing Li, Heng Xu, Yaomei Tian, Bailing Zhou, Yang Wang and Tao Chen. Their work appears in journals such as Frontiers in Pharmacology, Journal of Clinical Oncology, Scientific Reports, Clinical Cancer Research and BMC Cancer.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact